Our study demonstrated that genetic deletion of P2Y2R confers a significant resistance to HFD-induced obesity by decreasing hepatic steatosis, evidenced by a reduction in hepatic triglycerides and NAFLD activity scores. This evidence concerns the gene P2RY2 and fatty liver disease.